Please use this identifier to cite or link to this item:
Title: Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial.
Authors: Nicholson, KG
Abrams, KR
Batham, S
Clark, TW
Hoschler, K
Lim, WS
Medina, MJ
Nguyen-Van-Tam, JS
Read, RC
Warren, FC
Zambon, M
First Published: Feb-2011
Citation: LANCET INFECT DIS, 2011, 11 (2), pp. 91-101
Abstract: Effective antigen-sparing vaccines are needed to confront pandemic influenza. Whole-virion and oil-in-water adjuvanted vaccines are the most effective formulations against H5N1 avian influenza. We assessed the safety and immunogenicity in adults in the UK of pandemic H1N1 whole-virion vaccine and oil-in-water adjuvanted vaccine purchased by the UK government in 2009.
DOI Link: 10.1016/S1473-3099(10)70296-6
eISSN: 1474-4457
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Health Sciences

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.